Effects of troponin C isoform on the action of the cardiotonic agent EMD 57033.

Effects of troponin C isoform on the action of the cardiotonic agent EMD 57033.

The effects of the cardiotonic potentiator EMD 57033 on different TnC (troponin C) isoforms were investigated. Endogenous skeletal TnC was extracted from glycerinated, permeabilized rabbit psoas fibres and replaced with either purified native rabbit psoas TnC (fast TnC) or human recombinant cTnC (ca...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Lipscomb, S, Preston, L, Robinson, P, Redwood, C, Mulligan, I, Ashley, C
Formato:	Journal article
Idioma:	English
Publicado em:	2005

Registros relacionados

Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function.
por: Robinson, P, et al.
Publicado em: (2007)

DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation.
por: Preston, L, et al.
Publicado em: (2007)

Mechanical effects of human cardiac troponin C mutation Gly159Asp in exchanged rabbit psoas fibres
por: Preston, L, et al.
Publicado em: (2004)

Functional effects of the DCM mutant Gly159Asp troponin C in skinned muscle fibres.
por: Preston, L, et al.
Publicado em: (2007)

Study on the development of liquid extract of cardiotonic action
por: O. S. Kukhtenko, et al.
Publicado em: (2019-07-01)

Dilated cardiomyopathy causing mutations in cardiac troponin T (TNT), cardiac troponin C (TNC), and alpha tropomyosin (TM) reduce CA(2+) sensitivity and maximum calcium activation
por: Redwood, C, et al.
Publicado em: (2004)

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
por: Preston, L, et al.
Publicado em: (2006)

Cardiotonic Steroids as Modulators of Neuroinflammation
por: Ana Maria Marques Orellana, et al.
Publicado em: (2016-02-01)

Cardiotonic properties of high density lipoproteins
por: L. E. Panin, et al.
Publicado em: (2013-06-01)

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy
por: Elliott, K, et al.
Publicado em: (2000)

Mutations in fast skeletal troponin I, troponin T and beta-tropomyosin that cause distal arthrogryposis all enhance thin filament activation
por: Robinson, P, et al.
Publicado em: (2005)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
por: Redwood, C, et al.
Publicado em: (2001)

Using fluorescence emission spectroscopy to asses the Ca2+ affinity of reconstituted troponin and thin filaments containing cardiomyopathy causing mutations of troponin and alpha-tropomyosin
por: Robinson, P, et al.
Publicado em: (2007)

The cardiotonic properties of human apolipoprotein A-I
por: A. R. Kolpakov, et al.
Publicado em: (2015-12-01)

Usage of cardiotonic drugs at the intensive care units
por: Ruslan Baltaga, et al.
Publicado em: (2017-04-01)

EMBININ IS A PERSPECTIVE CARDIOTONIC MEAN FOR NATURAL ORIGIN
por: D. Yu. Ivkin, et al.
Publicado em: (2019-01-01)

Research Progress in Pharmacological Activities and Applications of Cardiotonic Steroids
por: Junwei Ren, et al.
Publicado em: (2022-06-01)

A Short Review on Cardiotonic Steroids and Their Aminoguanidine Analogues
por: Arturo San Feliciano, et al.
Publicado em: (2000-01-01)

C25 Phytochemical characterization and proposal of a cardiotonic mechanism of action of the methanolic extract of Caloncoba glauca (Flacourtiaceae) roots on isolated frog's heart
por: M. H. J Nko’o, et al.
Publicado em: (2023-12-01)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
por: Burton, D, et al.
Publicado em: (2002)

A convenient synthesis of cyclopenta[b]pyridin-2,5-dione as a non- glycosidic cardiotonic agent
por: Nicolas Robert, et al.
Publicado em: (2007-10-01)

Hypertrophic and dilated cardiomyopathycausing mutations of troponin and alpha-tropomyosin have opposite effects on thin filament calcium binding
por: Robinson, P, et al.
Publicado em: (2007)

Much More than a Cardiotonic Steroid: Modulation of Inflammation by Ouabain
por: Luiz H. A. Cavalcante-Silva, et al.
Publicado em: (2017-11-01)

Structure-function relationships of eight mutations in troponin and tropomyosin that cause dilated cardiomyopathy
por: Mirza, M, et al.
Publicado em: (2004)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
por: Robinson, P, et al.
Publicado em: (2003)

Investigating the Effect of Cardiomyopathy-Causing Mutations in Cardiac Troponin-T on Calcium Buffering In Situ
por: Robinson, P, et al.
Publicado em: (2010)

Periplocymarin Plays an Efficacious Cardiotonic Role via Promoting Calcium Influx
por: Weijing Yun, et al.
Publicado em: (2020-08-01)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
por: Robinson, P, et al.
Publicado em: (2007)

Na,K-ATPase as a target for endogenous cardiotonic steroids: What's the evidence?
por: Sergei N. Orlov, et al.
Publicado em: (2021-05-01)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
por: Robinson, P, et al.
Publicado em: (2002)

A troponin I mutant known to cause hypertrophic cardiomyopathy shows reduced inhibition of Ca2+ independent tension
por: Burton, D, et al.
Publicado em: (2000)

Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
por: Robinson, P, et al.
Publicado em: (2002)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
por: Carballo, S, et al.
Publicado em: (2006)

Two mutations in human cardiac troponin I known to cause hypertrophic cardiomyopathy have different effects on cardiac muscle contraction
por: Burton, D, et al.
Publicado em: (2000)

THE INFLUENCE OF UNDERLYING PRETRANSPLANT DISEASE ON CARDIOTONIC AND VASOACTIVE THERAPY IN EARLY PERIOD AFTER HEART TRANSPLANTATION
por: V. N. Poptsov, et al.
Publicado em: (2011-06-01)

Modulation of the effects of tropomyosin on actin and myosin conformational changes by troponin and Ca2+.
por: Borovikov, Y, et al.
Publicado em: (2009)

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.
por: Elliott, K, et al.
Publicado em: (2000)

Cardiotonic Pills Plus Recombinant Human Prourokinase Ameliorates Atherosclerotic Lesions in LDLR–/– Mice
por: Jing-Na Deng, et al.
Publicado em: (2019-09-01)

P81 Antibody to Cardiotonic Steroid Reduces Blood Pressure and Vascular Fibrosis in Preeclampsia
por: NI Agalakova, et al.
Publicado em: (2020-02-01)

Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy.
por: Mogensen, J, et al.
Publicado em: (2004)